The SRF is America’s largest nonprofit investor in scleroderma research and devotes a greater percentage of its annual budget to scleroderma research than any other nonprofit organization. Thanks in large part to the SRF and its many generous donors, research is progressing at a faster pace than ever before.
Learn more at srfcure.org
Narrated by SRF Board Member in Memoriam, Bob Saget.